Clinical Trial: Prophylactic Pulmonary Vein Isolation During Atrial Flutter Ablation

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649603) titled 'Prophylactic Pulmonary Vein Isolation During Atrial Flutter Ablation' on June 03.

Brief Summary: Pulmonary vein isolation (PVI) via catheter ablation has been successfully employed for years to treat symptomatic atrial fibrillation (AF). Moreover, PVI has not been used as a prophylactic intervention even in groups known to be high-risk for the future development of AF. Preliminary studies, including our pilot PREVENT AF I randomized trial, suggested that prophylactic PVI may be effective at reducing new onset AF and overall AF burden in atrial flutter (AFL) patients.

This is a multicenter single-blind randomized controlled trial, "...